RecruitingNot ApplicableNCT06080620

The Choice of Treatment Methods and Efficacy of LABC

Treatment Selection and Efficacy of Locally Advanced Breast cancer-a Prospective Randomized Controlled Study


Sponsor

Peking Union Medical College Hospital

Enrollment

50 participants

Start Date

Oct 8, 2023

Study Type

INTERVENTIONAL

Conditions

Summary

The goal of this clinical trial is to compare the therapeutic effects of chemotherapy followed by surgery and surgery followed by chemotherapy in patients with locally advanced breast cancer(LABC). Patients with LABC will be randomly divided into two groups, each receiving chemotherapy followed by surgery or surgery followed by chemotherapy. The main comparison was between the disease-free survival (DFS) of two groups of patients, with the secondary study endpoint being overall survival (OS); Five year survival; Local recurrence or distant metastasis rate.


Eligibility

Sex: FEMALEMin Age: 18 YearsMax Age: 70 Years

Plain Language Summary

Simplified for easier understanding

This study looks at the best combination of treatments — surgery, radiation, and chemotherapy — for women with locally advanced breast cancer (a larger or more involved tumor that hasn't spread to distant parts of the body). Researchers are tracking how well these approaches work and how they affect quality of life. **You may be eligible if...** - You are a woman between 18 and 70 years old - You have been newly diagnosed with locally advanced breast cancer (stage IIIb or IIIc) - Your tumor may be removable with surgery - You are willing to receive surgery, radiation, and chemotherapy - You are willing to complete quality-of-life questionnaires during follow-up **You may NOT be eligible if...** - You have already had breast cancer treatment (surgery, radiation, or chemotherapy) - You have a history of another cancer - You are pregnant or breastfeeding - You have a serious infection, fever, or major health conditions such as heart/lung/liver/kidney disease or poorly controlled diabetes Talk to your doctor to see if this trial is right for you.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

PROCEDUREModified radical mastectomy for breast cancer

Modified radical mastectomy for breast cancer

PROCEDUREneoadjuvant therapy

neoadjuvant chemotherapy(Drugs:" Doxorubicin""Paclitaxel""Albumin paclitaxel""Cyclophosphamide"), endocrine therapy(Drugs:"Toremifen""Zoladex""Aromatase inhibitors"), targeted therapy(Drugs:"trastuzumab""Pertuzumab")

PROCEDURESystematic treatment

chemotherapyDrugs:" Doxorubicin""Paclitaxel""Albumin paclitaxel""Cyclophosphamide"), endocrine therapy(Drugs:"Toremifen""Zoladex""Aromatase inhibitors"), targeted therapy(Drugs:"trastuzumab""Pertuzumab"),radiotherapy("Yikeda Versa HD linear accelerator""Varian Trilogy linear accelerator")


Locations(1)

Ying Xu

Beijing, China

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT06080620


Related Trials